LYMPHVASCULAR SPACE INVOLVEMENT - A PROGNOSTIC INDICATOR IN ENDOMETRIAL ADENOCARCINOMA

被引:78
作者
GAL, D
RECIO, FO
ZAMUROVIC, D
TANCER, ML
机构
[1] SUNY HLTH SCI CTR BROOKLYN,BROOKLYN,NY
[2] MAIMONIDES HOSP,DEPT GYNECOL ONCOL,BROOKLYN,NY 11219
[3] MAIMONIDES HOSP,DEPT PATHOL,BROOKLYN,NY 11219
[4] MAIMONIDES HOSP,DEPT OBSTET & GYNECOL,BROOKLYN,NY 11219
关键词
D O I
10.1016/0090-8258(91)90334-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study evaluates the effects of various prognostic indicators on survival of patients with clinical Stage I endometrial carcinoma. Ninety-three patients who were treated for clinical Stage I endometrial adenocarcinoma at Maimonides Medical Center from October 1979 to October 1987 had sufficient surgical-pathological information for retrospective surgical staging according to the new FIGO classification. Histology was reviewed. A new grade and surgical stage was assigned to each patient in accordance with the recent FIGO guidelines for surgical staging of corpus cancer. Poor prognostic indicators, namely, tumor grade, depth of myometrial invasion, peritoneal cytology, lymph node metastases, and lymphvascular space (LVS) involvement, were correlated with 5-year survival rates. Survival rates were calculated by the life table method. Depth of myometrial invasion, lymph node involvement, and peritoneal cytology had significant statistical correlation with poor survival. Positive finding of each of the prognostic indicators, including LVS involvement, was significantly associated with poor survival (all P < 0.001). The value of these prognostic indicators in early endometrial carcinoma is discussed. © 1991.
引用
收藏
页码:142 / 145
页数:4
相关论文
共 33 条
  • [1] AALDERS J, 1980, OBSTET GYNECOL, V56, P419
  • [2] BARBER HRK, 1978, OBSTET GYNECOL, V52, P343
  • [3] BLYTHE JG, 1986, AM J OBSTET GYNECOL, V153, P306
  • [4] BOYCE J, 1981, GYNECOL ONCOL, V12, P159
  • [5] EXTRAUTERINE SPREAD IN ENDOMETRIAL CARCINOMA CLINICALLY CONFINED TO THE UTERUS
    CHEN, SS
    [J]. GYNECOLOGIC ONCOLOGY, 1985, 21 (01) : 23 - 31
  • [6] CHEN SS, 1959, CANCER, V63, P1843
  • [7] CHERRY CP, 1955, CANCER, V8, P564, DOI 10.1002/1097-0142(1955)8:3<564::AID-CNCR2820080318>3.0.CO
  • [8] 2-A
  • [9] COWLES TA, 1985, OBSTET GYNECOL, V66, P413
  • [10] CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO